EGFR-Positive Non-Small Cell Lung Cancer (EGFR+ NSCLC) Clinical Trials Assessment 2024: FDA Approvals, Pipeline, Therapies, MOA, ROA and Companies by DelveInsight | Kairos Pharma (ENV105), Daiichi Sankyo, AbbVie, Akeso, Cullinan Oncology, EpimAb
(Albany, USA) As per DelveInsight's assessment, globally, about 40+ key pharma and biotech companies are working on 42+ pipeline drugs in the EGFR-Positive Non-Small Cell Lung Cancer therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years."EGFR-Positive Non-Small Cell Lung Cancer (EGFR + NSCLC) Pipeline Insight" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the EGFR-Positive Non-Small Cell Lung Cancer Therapeutics Market.
The report provides a detailed description of the EGFR-Positive Non-Small Cell Lung Cancer drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the EGFR-Positive Non-Small Cell Lung Cancer Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/egfr-non-small-cell-lung-cancer-egfr-nsclc-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
EGFR-Positive Non-Small Cell Lung Cancer (EGFR + NSCLC) Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing EGFR-Positive Non-Small Cell Lung Cancer therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for EGFR-Positive Non-Small Cell Lung Cancer treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging EGFR-Positive Non-Small Cell Lung Cancer drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the EGFR-Positive Non-Small Cell Lung Cancer treatment market.
Learn More about the Clinical and Commercial Development Activities in the EGFR-Positive Non-Small Cell Lung Cancer Therapeutics Domain @
https://www.delveinsight.com/report-store/egfr-non-small-cell-lung-cancer-egfr-nsclc-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
EGFR-Positive Non-Small Cell Lung Cancer (EGFR + NSCLC) Therapeutics Analysis
Approximately 40+ prominent pharma and biotech companies are actively involved in developing therapies for EGFR-Positive Non-Small Cell Lung Cancer. Among these, Akeso Biopharma stands out as a notable player, with its EGFR-Positive Non-Small Cell Lung Cancer drug candidates advancing to the most advanced stage, namely Phase III.
EGFR-Positive Non-Small Cell Lung Cancer (EGFR + NSCLC) Companies in the Therapeutics Market Include:
Some of the key companies in the EGFR + NSCLC Market include Alpha Biopharma, Daiichi Sankyo Company, Suzhou Puhe Pharmaceutical Technology, Checkpoint Therapeutics, AbbVie, Akeso Biopharma, Cullinan Oncology, Betta Pharmaceuticals, EpimAb Biotherapeutics, Genor Biopharma, G1 Therapeutics, JIntsBio, and many others.
Emerging and Marketed EGFR-Positive Non-Small Cell Lung Cancer (EGFR + NSCLC) Therapies Covered in the Report Include:
• AK112: Akeso Biopharma
• CLN-081: Cullinan Oncology
• BPI-361175: Betta Pharmaceuticals
• JANX008: Janux Therapeutics
• ENV105: Kairos Pharma
And Many More
Get an in-depth Assessment of the Emerging Therapies and EGFR-Positive Non-Small Cell Lung Cancer Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/egfr-non-small-cell-lung-cancer-egfr-nsclc-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
The Report Covers the Emerging EGFR-Positive Non-Small Cell Lung Cancer Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates
Route of Administration
EGFR-Positive Non-Small Cell Lung Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Intravenous
• Subcutaneous
• Parenteral
• Topical
Molecule Type
Products have been categorized under various Molecule types such as
• Recombinant fusion proteins
• Small molecule
• Monoclonal antibody
• Peptide
• Polymer
• Gene therapy
Request for Sample PDF to Understand More About the EGFR-Positive Non-Small Cell Lung Cancer Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/egfr-non-small-cell-lung-cancer-egfr-nsclc-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Content
1. Report Introduction
2. Executive Summary
3. EGFR-Positive Non-Small Cell Lung Cancer Current Treatment Patterns
4. EGFR-Positive Non-Small Cell Lung Cancer - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. EGFR-Positive Non-Small Cell Lung Cancer Late-Stage Products (Phase-III)
7. EGFR-Positive Non-Small Cell Lung Cancer Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. EGFR-Positive Non-Small Cell Lung Cancer Discontinued Products
13. EGFR-Positive Non-Small Cell Lung Cancer Product Profiles
14. EGFR-Positive Non-Small Cell Lung Cancer Companies
15. EGFR-Positive Non-Small Cell Lung Cancer Drugs
16. Dormant and Discontinued Products
17. EGFR-Positive Non-Small Cell Lung Cancer Unmet Needs
18. EGFR-Positive Non-Small Cell Lung Cancer Future Perspectives
19. EGFR-Positive Non-Small Cell Lung Cancer Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/egfr-non-small-cell-lung-cancer-egfr-nsclc-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Trending Reports:
• Adrenal Insufficiency Market: https://www.delveinsight.com/report-store/adrenal-crisis-market
• Antibody Mediated Rejection Market: https://www.delveinsight.com/report-store/antibody-mediated-rejection-market
• Antibody-mediated Rejection Market: https://www.delveinsight.com/report-store/antibody-mediated-rejection-market
• Bone And Joint Infection Market: https://www.delveinsight.com/report-store/prosthetic-joint-infection-market
• Cholangiocarcinoma Market: https://www.delveinsight.com/report-store/cholangiocarcinoma-cca-market-insights-epidemiology-and-market-forecast
• Cutaneous Lupus Erythematosus Market: https://www.delveinsight.com/report-store/cutaneous-lupus-erythematosus-market
• Human Papillomavirus Positive Cancer Market: https://www.delveinsight.com/report-store/human-papillomavirus-16-positive-hpv16-cancers-market
• Italy Healthcare Outlook Report: https://www.delveinsight.com/report-store/italy-healthcare-outlook-report
• Postmenopausal Vaginal Atrophy Market: https://www.delveinsight.com/infographics/atrophic-vaginitis-market
• Severe Hypertriglyceridemia Market: https://www.delveinsight.com/report-store/severe-hypertriglyceridemia-shtg-market
• Abscess Market: https://www.delveinsight.com/report-store/abscess-market
• Acute Ischemic Stroke Ais Market: https://www.delveinsight.com/report-store/acute-ischemic-stroke-ais-market
• Adrenoleukodystrophy Market: https://www.delveinsight.com/blog/adrenoleukodystrophy-market-size
• Cutaneous T-cell Lymphoma Market: https://www.delveinsight.com/infographics/cutaneous-t-cell-lymphoma-ctcl-market
• Diffuse Cutaneous Systemic Sclerosis Market: https://www.delveinsight.com/report-store/diffuse-cutaneous-systemic-sclerosis-dcssc-market
• Lhon Market: https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market
• Uncomplicated Urinary Tract Infections Market: https://www.delveinsight.com/report-store/uncomplicated-urinary-tract-infection-uuti-market
• Ataxia Telangiectasia Market: https://www.delveinsight.com/report-store/ataxia-telangiectasia-at-market
• Atypical Hemolytic Uremic Syndrome Ahus Market: https://www.delveinsight.com/report-store/atypical-hemolytic-uremic-syndrome-ahus-market
• Biliary Atresia Market: https://www.delveinsight.com/report-store/biliary-atresia-market
• Biliary Tract Cancer Market: https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-market
• Chronic Inducible Urticaria Market: https://www.delveinsight.com/report-store/chronic-spontaneous-urticaria-market
• Chronic Refractory Gout Market: https://www.delveinsight.com/report-store/chronic-refractory-gout-market
• Diffuse Large B-cell Lymphoma Market: https://www.delveinsight.com/report-store/diffuse-large-b-cell-lymphoma-market
• Myelofibrosis Market: https://www.delveinsight.com/report-store/myelofibrosis-mf-market
• Severe Hypoglycemia Market: https://www.delveinsight.com/report-store/severe-hypoglycemia-market
• Ankylosing Spondylitis Bekhterevs Disease Market: https://www.delveinsight.com/report-store/ankylosing-spondylitis-bekhterevs-disease-market
• Cutaneous T Cell Lymphoma Market: https://www.delveinsight.com/infographics/cutaneous-t-cell-lymphoma-ctcl-market
• Epidermolysis Bullosa Market: https://www.delveinsight.com/report-store/epidermolysis-bullosa-market
• Idiopathic Membranous Nephropathy Market: https://www.delveinsight.com/report-store/idiopathic-membranous-nephropathy-imn-market
• Sjogren's Syndrome Market: https://www.delveinsight.com/report-store/sjogrens-syndrome-market-size
• Balloon Catheters Market: https://www.delveinsight.com/report-store/balloon-catheters-market
• Balloon Catheters Market Market: https://www.delveinsight.com/report-store/balloon-catheters-market
• Central Retinal Venous Occulsion Market: https://www.delveinsight.com/report-store/retinal-vein-occlusion-market
• Community-acquired Bacterial Pneumonia Market: https://www.delveinsight.com/report-store/community-acquired-bacterial-pneumonia-cabp-market
• Multiple Myeloma Market: https://www.delveinsight.com/report-store/multiple-myeloma-market
• Achromatopsia Market: https://www.delveinsight.com/report-store/achromatopsia-market
• Atopic Keratoconjunctivitis Akc Market: https://www.delveinsight.com/report-store/atopic-keratoconjunctivitis-market
• Bipolar Depression Market: https://www.delveinsight.com/report-store/bipolar-disorder-manic-depression-market
• Cardiac Insufficiency Market: https://www.delveinsight.com/report-store/congestive-heart-failure-market
• Chronic Pain Associated With Painful Diabetic Neuropathy Market: https://www.delveinsight.com/blog/chronic-pain-associated-with-painful-diabetic-neuropathy-market
• Tim-3-next Generation Immunotherapy Market: https://www.delveinsight.com/infographics/tim-3-next-generation-immunotherapy-competitive-landscape
• Asmd Market: https://www.delveinsight.com/report-store/acid-sphingomyelinase-deficiency-asmd-market
• Calciphylaxis Market: https://www.delveinsight.com/report-store/calciphylaxis-market
• Chronic Idiopathic Urticaria Market: https://www.delveinsight.com/report-store/chronic-spontaneous-urticaria-market
• Atypical Teratoid Rhabdoid Tumors Market: https://www.delveinsight.com/report-store/atypical-teratoid-rhabdoid-tumors-market
• Cardiac Amyloidosis Market: https://www.delveinsight.com/report-store/al-amyloidosis-market
• Healthcare Pipeline Analysis: https://www.delveinsight.com/consulting/pipeline-assessment-services
• Hepatitis D Market: https://www.delveinsight.com/report-store/hepatitis-d-market
• Interbody Cages Market: https://www.delveinsight.com/report-store/interbody-cages-market
• Endoscopy Fluid Management Systems Market: https://www.delveinsight.com/blog/endoscopy-fluid-management-systems-market
• Helicobacter Pylori Infection Market: https://www.delveinsight.com/report-store/helicobacter-pylori-infections-market
• Lymphocytopenia Market: https://www.delveinsight.com/report-store/lymphocytopenia-market
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/asco-conference-coverage
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release EGFR-Positive Non-Small Cell Lung Cancer (EGFR+ NSCLC) Clinical Trials Assessment 2024: FDA Approvals, Pipeline, Therapies, MOA, ROA and Companies by DelveInsight | Kairos Pharma (ENV105), Daiichi Sankyo, AbbVie, Akeso, Cullinan Oncology, EpimAb here
News-ID: 3606265 • Views: …
More Releases from DelveInsight Business Research
Non-Small Cell Lung Cancer Clinical Trials 2024: FDA Approvals, Pipeline, Therap …
DelveInsight's, "Non-Small-Cell Lung Cancer Pipeline Insight 2024" report provides comprehensive insights about 135+ Non-Small Cell Lung Cancer Companies and 150+ pipeline drugs in the Non-Small-Cell Lung cancer (NSCLC) pipeline landscape. It covers the Non-Small Cell Lung Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Non-Small Cell Lung Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights…
Sphingosine 1 Phosphate Receptor (S1PR) Modulators Market Projected for Strong G …
(Albany, USA) DelveInsight's Sphingosine 1 Phosphate Receptor (S1PR) Modulators Market Insights report offers a thorough understanding of prevailing treatment protocols, emerging therapies, individual therapy market shares, and the projected market size for Sphingosine 1 Phosphate Receptor (S1PR) Modulators from 2019 to 2032. The market analysis is segmented across the 7MM, encompassing the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan.
The Sphingosine 1 Phosphate Receptor…
Opioid Kappa Receptor Agonists Market Poised for Remarkable Growth by 2034, Repo …
(Albany, USA) DelveInsight's Opioid Kappa Receptor Agonists Market Insights report offers a thorough understanding of prevailing treatment protocols, emerging therapies, individual therapy market shares, and the projected market size for Opioid Kappa Receptor Agonists from 2020 to 2034. The market analysis is segmented across the 7MM, encompassing the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan.
The Opioid Kappa Receptor Agonists market size is anticipated…
Tinnitus Clinical Trials 2024: FDA Approvals, Pipeline, Therapies, Treatment Mar …
(Albany, USA) Tinnitus pipeline constitutes 7+ key companies continuously working towards developing 8+ Tinnitus treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Tinnitus Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Tinnitus Market.
The Tinnitus Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental…
More Releases for Market:
India Tractor Market, Tractor Industry, Market Revenue, Market Growth Analysis, …
How Is India Tractor Market Positioned?
In India two-third population is engaged in Agriculture. Tractors form an essential part of this sector. They bring the required efficiency and productivity country needs in its agricultural activity to compete on the international level. The Indian tractor Industry has made preponderant improvement in production capacity and in terms of production volumes. The industry has been successful in indigenization of the technology. The volume growth…
Global Optical Interconnects Market, Market Size, Market Shares, Market Growth A …
In integrated circuits, optical interconnects majorly refers to a system of transmitting signals from one fragment of an integrated circuit to another part which is using light. Optical interconnects have been in high demand due to the high latency and power consumption incurred by conventional metal interconnects in conveying electrical signals over long distances, such as in interconnects classed as global interconnects.
The International Technology Roadmap for Semiconductors (ITRS) has emphasized…
Global Cash Registers Market, Market Growth Analysis, Market Revenue, Market Out …
A cash register or automatic money handling system is a motorized or electric device for registration and calculating dealings at a point of sale. It is typically devoted to a drawer for storage cash and additional valuables. A modern cash register is generally attached to a printer which can print out incomes for record-keeping determinations. The electronics cash register delivers numerous features likes mall price and informal admittance. The rising acceptance of electronic cash register by…
Global Organic Food & Beverage Market | Market Size, Market Share, Market Trends …
The term 'organic' has gained much popularity since the last decade, which refers to the process of how certain foods are produced. Organic food is grown without the use of synthetic chemicals, such as human-made pesticides and fertilizers, and does not contain genetically modified organisms (GMOs). According to the recently published report titled, 'Global Organic Food & Beverage Outlook, 2026', by Bonafide Research the organic foods & beverage industry has…
Robotic Cardiology Surgery Market Insights Includes Market Share, Market Researc …
Robotic Cardiology Surgery Market
Global demand for cardiac surgery robots in 2025 will explode to $XXX billion. This represents an astonishing XX% growth yearly in terms of annual revenue between 2016 and 2025, and a cumulative market total of $7.50 billion during 2017-2025 owing to the substantial increase of robot-based and computer-assisted cardiological surgery procedures for heart disorders.
Global Robotic Cardiology Surgery Market 2016-2025: Market Size, Share, Forecast and Strategy is based…
Educational Robots Market, Market Segmentation, Market Report, Market Forecast
Global Educational Robots market valued USD 670 Million in 2017 and is likely to grow more than USD 2339.8 Million by 2025 with a compounded annual growth of 16.92% over the forecast period 2018-2025. The market growth is primarily driven by technological enhancements in the field of robotics and increasing use of robots for educational purposes. However, high initial research and development expenses hamper market growth. The main function of…